K-ras, BRCA1/2, and CHEK2 mutations and loss of heterozygosity at 9p, 17p, and 18q in sporadic adenocarcinoma of the pancreas
Authors:
- 23 June 2009
- journal article
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 43 (3) , 381-387
Abstract
The diagnostic significance of molecular markers was assessed for the most common somatic aberrations at the K-ras, TP53, CDKN2A, and MADH4 loci, as well as less common mutations of BRCA1, BRCA2, and CHEK2, arising in preinvasive stages of sporadic adenocarcinoma of the pancreas. The study was performed on paired primary pancreatic adenocarcinoma and normal pancreatic tissue specimens obtained from 37 Russian patients. Surgical adenocarcinoma specimens were subjected to manual microdissection. Mutations of K-ras codon 12 were found in 24 tumor specimens (0.65), but not in normal pancreatic tissue specimens. Mutations of BRCA1 (185delAG, 300T > G, 4153delA, 4158A > G, 5382insC), BRCA2 (695insT, 6174delT), and CHEK2 (1100delC) were not found. The informativeness of allelic losses did not differ significantly among the three tumor suppressor loci and was 60% for TP53 (GDB186817) and CDKN2A (D9S974 + D9S162) and 65.7% for MADH4 (D18S363 + D18S474) (t = 0.48). The CDKN2A locus had the highest LOH frequency of 0.95. For TP53 and MADH4 the LOH frequency was 0.62 and 0.70, respectively. In 80% of adenocarcinomas, at least one locus was characterized with LOH. The overall informativeness of the combined data on K-ras mutations and loss of heterozygosity at 9p, 17p, and 18q was 85.7%. Only 9% of the tumors were characterized with microsatellite instability.Keywords
This publication has 22 references indexed in Scilit:
- Biochip analysis of BRCA1/2 and CHEK2 common mutations in ovarian cancer and primary multiple tumors involving the ovaries (Russian population)Molecular Biology, 2007
- Clinical Cancer Advances 2006: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical OncologyJournal of Clinical Oncology, 2007
- Role of BRCA1 and BRCA2 mutations in pancreatic cancerGut, 2006
- Microsatellite DNA Alterations of Gastrointestinal Stromal Tumors Are Predictive for OutcomeClinical Cancer Research, 2006
- Development of a Biochip for Analyzing Polymorphism of the Biotransformation GenesMolecular Biology, 2005
- BRCA1 and pancreatic cancer: pedigree findings and their causal relationshipsCancer Genetics and Cytogenetics, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Pancreatic cancer biology and geneticsNature Reviews Cancer, 2002
- Integration of Multiple PCR Amplifications and DNA Mutation Analyses by Using Oligonucleotide MicrochipAnalytical Biochemistry, 2001
- Pancreatic Intraepithelial NeoplasiaAmerican Journal of Surgical Pathology, 2001